Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
2001

HPV Testing for Cervical Cancer Screening

Sample size: 7932 publication Evidence: high

Author Information

Author(s): Clavel C, Masure M, Bory J-P, Putaud I, Mangeonjean C, Lorenzato M, Nazeyrollas P, Gabriel R, Quereux C, Birembaut P

Primary Institution: C.H.U. de Reims

Hypothesis

Can HR-HPV DNA detection in primary routine screening effectively detect high-grade cervical lesions?

Conclusion

HR-HPV testing is a highly sensitive method for detecting high-grade cervical lesions and can improve screening outcomes when used alongside cytology.

Supporting Evidence

  • The sensitivity of HPV testing for detecting HGSIL was found to be 100%.
  • Conventional cytology had a sensitivity of only 68.1%, while liquid-based cytology had 87.8%.
  • HPV testing's specificity improved when restricted to women over 30 years old.

Takeaway

This study found that testing for a virus called HPV can help find serious cervical problems in women better than traditional methods.

Methodology

The study involved HPV testing using the Hybrid Capture II assay and cytologic techniques on women undergoing routine cervical examinations.

Limitations

The study's specificity was relatively low, and the reliability of viral load assessment in normal smears was questioned.

Participant Demographics

Women undergoing routine cervical examination, with a focus on those over 30 for improved specificity.

Digital Object Identifier (DOI)

10.1054/bjoc.2001.1845

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication